Immatics NV (IMTX)

[jondoeuk]

Still early, but based on the data, and the fact that BMY abandoned IMA401, it isn't a great vote of confidence in their bispecific platform https://markets.businessinsider.com/news/stocks/immatics-announces-clinical-data-on-tcer-ima402-targeting-prame-1034031315